Optimization of cardiac performance in chronic heart failure patients undergoing elective non-cardiac surgery

Current Anaesthesia and Critical Care

Volumn 18, Issue 1, 2007, Pages 50-57

  Toufektzian, Levon ^a   Theodorou, Dimitrios ^a   Larentzakis, Andreas ^a   Misthos, Panagiotis ^b   Katsaragakis, Stylianos ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b HYGEIA HOSPITAL   (Greece)

Author keywords

Heart failure; Non cardiac surgery; Pharmacological treatment; Preoperative evaluation

Indexed keywords

ALDOSTERONE; ALDOSTERONE ANTAGONIST; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; BRADYKININ; CAPTOPRIL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOBUTAMINE; ENALAPRIL; FUROSEMIDE; GLYCERYL TRINITRATE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INOTROPIC AGENT; LEVOSIMENDAN; MEVINOLIN; MILRINONE; NESIRITIDE; NITRIC OXIDE; NITROPRUSSIDE SODIUM; NORADRENALIN; PROSTACYCLIN; UNINDEXED DRUG; VASODILATOR AGENT; VASOPRESSIN;

ANESTHESIA INDUCTION; ARTICLE; CLINICAL TRIAL; DIASTOLIC DYSFUNCTION; DRUG FATALITY; DRUG WITHDRAWAL; ELECTIVE SURGERY; HEART ARREST; HEART ARRHYTHMIA; HEART DISEASE; HEART FAILURE; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE OXYGEN CONSUMPTION; HEART MUSCLE REVASCULARIZATION; HEART PERFORMANCE; HEART RATE; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERCALCEMIA; HYPERKALEMIA; HYPOKALEMIA; HYPOMAGNESEMIA; HYPOTENSION; HYPOVOLEMIA; LUNG EMBOLISM; PATIENT CARE; PERIOPERATIVE PERIOD; POSTOPERATIVE PERIOD; PRACTICE GUIDELINE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; PULMONARY ARTERY CATHETER; SIDE EFFECT; SURGICAL MORTALITY; SURGICAL STRESS; SYSTOLIC DYSFUNCTION; TACHYCARDIA; TRANSTHORACIC ECHOCARDIOGRAPHY;

EID: 34347253046     PISSN: 09537112     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cacc.2007.03.016     Document Type: Article

References (42)

1. Kannel W.B. Epidemiology and prevention of cardiac failure: Framingham Study insights. Eur Heart J 8 Suppl. F (1987) 23-26
2. Rich M.W. Epidemiology, pathophysiology, and etiology of congestive heart failure in older adults. J Am Geriatr Soc 45 8 (1997) 968-974
3. Hernandez A.F., Whellan D.J., Stroud S., Sun J.L., O'Connor C.M., and Jollis J.G. Outcomes in heart failure patients after major noncardiac surgery. J Am Coll Cardiol 44 7 (2004) 1446-1453
4. Eagle K.A., Berger P.B., Calkins H., Chaitman B.R., Ewy G.A., Fleischmann K.E., et al. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). J Am Coll Cardiol 39 3 (2002) 542-553
5. Erratum in: J Am Coll Cardiol 2006;47(11):2356.
6. Larsen S.F., Olesen K.H., Jacobsen E., Nielsen H., Nielsen A.L., Pietersen A., et al. Prediction of cardiac risk in non-cardiac surgery. Eur Heart J 8 2 (1987) 179-185
7. Goldman L., Caldera D.L., Nussbaum S.R., Southwick F.S., Krogstad D., Murray B., et al. Multifactorial index of cardiac risk in noncardiac surgical procedures. N Engl J Med 297 16 (1977) 845-850
8. Mangano D.T., Browner W.S., Hollenberg M., London M.J., Tubau J.F., and Tateo I.M. Association of perioperative myocardial ischemia with cardiac morbidity and mortality in men undergoing noncardiac surgery. The Study of Perioperative Ischemia Research Group. N Engl J Med 323 26 (1990) 1781-1788
9. Cohn J.N., and Tognoni G. Valsartan Heart Failure Trial Investigators. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. N Engl J Med 345 23 (2001) 1667-1675 Summary for patients in: J Card Fail 2002;8(2):56-8
10. Varin R., Mulder P., Tamion F., Richard V., Henry J.P., Lallemand F., et al. Improvement of endothelial function by chronic angiotensin-converting enzyme inhibition in heart failure: role of nitric oxide, prostanoids, oxidant stress, and bradykinin. Circulation 102 3 (2000) 351-356
11. Colson P., Ryckwaert F., and Coriat P. Renin angiotensin system antagonists and anesthesia. Anesth Analg 89 5 (1999) 1143-1155
12. Colson P., Saussine M., Seguin J.R., Cuchet D., Chaptal P.A., and Roquefeuil B. Hemodynamic effects of anesthesia in patients chronically treated with angiotensin-converting enzyme inhibitors. Anesth Analg 74 6 (1992) 805-808
13. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet 1999;353(9146):9-13.
14. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 1999;353(9169):2001-7.
15. Lindenauer P.K., Pekow P., Wang K., Mamidi D.K., Gutierrez B., and Benjamin E.M. Perioperative beta-blocker therapy and mortality after major noncardiac surgery. N Engl J Med 353 4 (2005) 349-361
16. Hunt SA, Baker DW, Chin MH, Cinquegrani MP, Feldman AM, Francis GS, et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol 2001;38(7):2101-13.
17. Farquharson C.A., and Struthers A.D. Spironolactone increases nitric oxide bioactivity, improves endothelial vasodilator dysfunction, and suppresses vascular angiotensin I/angiotensin II conversion in patients with chronic heart failure. Circulation 101 6 (2000) 594-597
18. Bertrand M., Godet G., Meersschaert K., Brun L., Salcedo E., and Coriat P. Should the angiotensin II antagonists be discontinued before surgery?. Anesth Analg 92 1 (2001) 26-30
19. Detsky A.S., Abrams H.B., McLaughlin J.R., Drucker D.J., Sasson Z., Johnston N., et al. Predicting cardiac complications in patients undergoing non-cardiac surgery. J Gen Intern Med 1 4 (1986) 211-219
20. Domanski M.J., Davis B.R., Pfeffer M.A., Kastantin M., and Mitchell G.F. Isolated systolic hypertension: prognostic information provided by pulse pressure. Hypertension 34 3 (1999) 375-380
21. Cooper H.A., Dries D.L., Davis C.E., Shen Y.L., and Domanski M.J. Diuretics and risk of arrhythmic death in patients with left ventricular dysfunction. Circulation 100 12 (1999) 1311-1315
22. El-Salawy S.M., Lowenthal D.T., Ippagunta S., and Bhinder F. Clinical pharmacology and physiology conference: digoxin toxicity in the elderly. Int Urol Nephrol 37 3 (2005) 665-668
23. Lindenauer P.K., Pekow P., Wang K., Gutierrez B., and Benjamin E.M. Lipid-lowering therapy and in-hospital mortality following major noncardiac surgery. JAMA 291 17 (2004) 2092-2099
24. Poldermans D., Bax J.J., Kertai M.D., Krenning B., Westerhout C.M., Schinkel A.F., et al. Statins are associated with a reduced incidence of perioperative mortality in patients undergoing major noncardiac vascular surgery. Circulation 107 14 (2003) 1848-1851
25. O'Neil-Callahan K., Katsimaglis G., Tepper M.R., Ryan J., Mosby C., Ioannidis J.P., et al. Statins decrease perioperative cardiac complications in patients undergoing noncardiac vascular surgery: the Statins for Risk Reduction in Surgery (StaRRS) study. J Am Coll Cardiol 45 3 (2005) 336-342
26. Publication Committee for the VMAC Investigators (Vasodilatation in the Management of Acute CHF). Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial. JAMA 287 12 (2002) 1531-1540 Erratum in: JAMA 2002;288(5):577
27. Burger A.J., Horton D.P., LeJemtel T., Ghali J.K., Torre G., Dennish G., et al. Prospective Randomized Evaluation of Cardiac Ectopy with Dobutamine or Natrecor Therapy. Effect of nesiritide (B-type natriuretic peptide) and dobutamine on ventricular arrhythmias in the treatment of patients with acutely decompensated congestive heart failure: the PRECEDENT study. Am Heart J 144 6 (2002) 1102-1108
28. Abraham WT, Adams KF, Fonarow GC, Costanzo MR, Berkowitz RL, LeJemtel TH, et al. ADHERE Scientific Advisory Committee and Investigators; ADHERE Study Group. In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE). J Am Coll Cardiol 2005;46(1):57-64.
29. Sackner-Bernstein J.D., and Mancini D.M. Rationale for treatment of patients with chronic heart failure with adrenergic blockade. JAMA 274 18 (1995) 1462-1467
30. Stevenson L.W., and Tillisch J.H. Maintenance of cardiac output with normal filling pressures in patients with dilated heart failure. Circulation 74 6 (1986) 1303-1308
31. Kapralou A, Theodorou D, Drimousis P, Larentzakis A, Kofinas G, Stamou K, et al. Levosimendan optimizes cardiac performance in chronic heart failure patients undergoing non-cardiac surgery [in press].
32. Moiseyev V.S., Poder P., Andrejevs N., Ruda M.Y., Golikov A.P., Lazebnik L.B., et al. Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction. A randomized, placebo-controlled, double-blind study (RUSSLAN). Eur Heart J 23 18 (2002) 1422-1432
33. Binanay C., Califf R.M., Hasselblad V., O'Connor C.M., Shah M.R., Sopko G., et al. Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial. JAMA 294 13 (2005) 1625-1633
34. Schwann N.M., and Mangano D.T. Multicenter Study of Perioperative Ischemia Research Group. Pulmonary-artery catheters in high-risk surgical patients. N Engl J Med 348 20 (2003) 2035-2037 [author reply 2035-7]
35. Kaluza G.L., Joseph J., Lee J.R., Raizner M.E., and Raizner A.E. Catastrophic outcomes of noncardiac surgery soon after coronary stenting. J Am Coll Cardiol 35 5 (2000) 1288-1294
36. Allen J.R., Helling T.S., and Hartzler G.O. Operative procedures not involving the heart after percutaneous transluminal coronary angioplasty. Surg Gynecol Obstet 173 4 (1991) 285-288
37. Satler L.F. Recommendations regarding stent selection in relation to the timing of noncardiac surgery postpercutaneous coronary intervention. Catheter Cardiovasc Interv 63 2 (2004) 146-147
38. Halm E.A., Browner W.S., Tubau J.F., Tateo I.M., and Mangano D.T. Echocardiography for assessing cardiac risk in patients having noncardiac surgery. Study of Perioperative Ischemia Research Group. Ann Intern Med 125 6 (1996) 433-441 Erratum in: Ann Intern Med 1997;126(6):494
39. Rohde L.E., Polanczyk C.A., Goldman L., Cook E.F., Lee R.T., and Lee T.H. Usefulness of transthoracic echocardiography as a tool for risk stratification of patients undergoing major noncardiac surgery. Am J Cardiol 87 5 (2001) 505-509
40. Eagle K.A., Coley C.M., Newell J.B., Brewster D.C., Darling R.C., Strauss H.W., et al. Combining clinical and thallium data optimizes preoperative assessment of cardiac risk before major vascular surgery. Ann Intern Med 110 11 (1989) 859-866
41. Colreavy F.B., Donovan K., Lee K.Y., and Weekes J. Transesophageal echocardiography in critically ill patients. Crit Care Med 30 5 (2002) 989-996
42. Eisenberg M.J., London M.J., Leung J.M., Browner W.S., Hollenberg M., Tubau J.F., et al. Monitoring for myocardial ischemia during noncardiac surgery. A technology assessment of transesophageal echocardiography and 12-lead electrocardiography. The Study of Perioperative Ischemia Research Group. JAMA 268 2 (1992) 210-216